These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30247811)

  • 21. Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.
    Butkiewicz M; Lowe EW; Mueller R; Mendenhall JL; Teixeira PL; Weaver CD; Meiler J
    Molecules; 2013 Jan; 18(1):735-56. PubMed ID: 23299552
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Morita K; Kato M; Kudo T; Ito K
    Xenobiotica; 2020 Sep; 50(9):1064-1075. PubMed ID: 32125203
    [No Abstract]   [Full Text] [Related]  

  • 23. Interlaboratory Variability in Human Hepatocyte Intrinsic Clearance Values and Trends with Physicochemical Properties.
    Bowman CM; Benet LZ
    Pharm Res; 2019 May; 36(8):113. PubMed ID: 31152241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Reference Data Selection for the Prediction Accuracy of Intrinsic Hepatic Metabolic Clearance.
    Fagerholm U; Spjuth O; Hellberg S
    J Pharm Sci; 2022 Sep; 111(9):2645-2649. PubMed ID: 35793746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro-In Vivo Extrapolation and Scaling Factors for Clearance of Human and Preclinical Species with Liver Microsomes and Hepatocytes.
    Tess D; Chang GC; Keefer C; Carlo A; Jones R; Di L
    AAPS J; 2023 Apr; 25(3):40. PubMed ID: 37052732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity, assay and target data curation and quality in the ChEMBL database.
    Papadatos G; Gaulton A; Hersey A; Overington JP
    J Comput Aided Mol Des; 2015 Sep; 29(9):885-96. PubMed ID: 26201396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Design and Success of Prospective Mouse In Vitro-In Vivo Extrapolation (IVIVE) for Predictions of Plasma Clearance (CL
    Manevski N; Umehara K; Parrott N
    Mol Pharm; 2023 Jul; 20(7):3438-3459. PubMed ID: 37235687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance.
    Ekins S; Obach RS
    J Pharmacol Exp Ther; 2000 Nov; 295(2):463-73. PubMed ID: 11046077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of the Contribution Ratio of a Target Metabolic Enzyme to Clearance from Chemical Structure Information.
    Watanabe R; Kawata T; Ueda S; Shinbo T; Higashimori M; Natsume-Kitatani Y; Mizuguchi K
    Mol Pharm; 2023 Jan; 20(1):419-426. PubMed ID: 36538346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.
    Obrezanova O; Martinsson A; Whitehead T; Mahmoud S; Bender A; Miljković F; Grabowski P; Irwin B; Oprisiu I; Conduit G; Segall M; Smith GF; Williamson B; Winiwarter S; Greene N
    Mol Pharm; 2022 May; 19(5):1488-1504. PubMed ID: 35412314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug metabolic stability in early drug discovery to develop potential lead compounds.
    Gajula SNR; Nadimpalli N; Sonti R
    Drug Metab Rev; 2021 Aug; 53(3):459-477. PubMed ID: 34406889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of in vivo carbamazepine 10,11-epoxidation from in vitro metabolic studies with human liver microsomes: importance of its sigmoidal kinetics.
    Sakamoto M; Itoh T; Fujiwara R
    Biol Pharm Bull; 2013; 36(12):1959-63. PubMed ID: 24292054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.
    Kosugi Y; Hosea N
    Mol Pharm; 2021 Mar; 18(3):1071-1079. PubMed ID: 33512165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic Target Fishing with Accurate Machine Learning Models.
    Sánchez-Cruz N; Medina-Franco JL
    J Med Chem; 2021 Jun; 64(12):8208-8220. PubMed ID: 33770434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the Extended Clearance Classification System (ECCS) in Drug Discovery and Development: Selection of Appropriate In Vitro Tools and Clearance Prediction.
    Umehara K; Cantrill C; Wittwer MB; Di Lenarda E; Klammers F; Ekiciler A; Parrott N; Fowler S; Ullah M
    Drug Metab Dispos; 2020 Oct; 48(10):849-860. PubMed ID: 32739889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Symbolic Regression Model for the Prediction of Drug Binding to Human Liver Microsomes.
    Van Rompaey D; Morrison D; Van Den Bergh A; Wegner JK
    Mol Pharm; 2023 May; 20(5):2436-2442. PubMed ID: 37000176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug Discovery.
    Patel M; Riede J; Bednarczyk D; Poller B; Deshmukh SV
    Pharm Res; 2023 Apr; 40(4):937-949. PubMed ID: 36859748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CAPi: Computational Model for Apicoplast Inhibitors Prediction Against Plasmodium Parasite.
    Dixit S; Singla D
    Curr Comput Aided Drug Des; 2017 Nov; 13(4):303-310. PubMed ID: 28260517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
    Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
    Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.